Back

David Nauman

Patent Agent, Partner

Location

Vancouver

Phone

604.632.3445

Contact

[email protected]

David’s intellectual property practice focuses on obtaining, evaluating and advising on patent protection. He is regularly involved in obtaining patent protection on behalf of corporate, government and academic clients in the life sciences and manufacturing sectors.

David’s areas of expertise include:

patent applications related to biotechnology, life sciences, pharmaceuticals, therapeutics, medical devices, chemistry, and oil and gas
patentability, validity, infringement and freedom-to-operate issues
international patent strategies and portfolio management

After graduate school, David worked in Ottawa at the Children’s Hospital of Eastern Ontario as a research associate and at a start-up biotechnology company. He has conducted research in the areas of synthetic organic chemistry, cell surface remodelling, and molecular and cellular biology.

David provides legal services through a Law Corporation.

Experience

Drafted and prosecuted patent applications related to:
- anti-cancer viruses
- insect pheromone compositions
- chemical catalysts
- water treatment systems
- solid phase micro-extraction
- glycopeptide compositions
- glass microparticle compositions
Examples include:
- European Patent No. 2 510 088 (“Oncolytic Rhabdovirus”)
- European Patent No. 2 718 427 (“Compositions for Glioblastoma treatment”)
- European Patent No. 3 061 345 (“Sex pheromone derivatives, and methods and uses thereof”)
- PCT Application No. CA2016/050622 (“Ligand for catalyst or pre-catalyst and method of forming C(sp2)-N bond”)
- PCT Application No. CA2018/051078 (“Chiral catalyst and method for asymmetric reduction of an imine”)
- U.S. Patent No. 9,783,443 (“Treatment of water to extend half-life of ozone”)
- PCT Application No.s CA2015/050551, CA2015/050550, CA2017/050279, and CA2017/050562 (all related to solid phase micro-extraction)
Managed global patent portfolios related to:
- vaccine formulation and development
- devices for micro-extraction of biological analytes
- water treatment systems
- anti-cancer viruses
- delivery and detection of embolic particles

Drafted and prosecuted patent applications related to:
- anti-cancer viruses
- insect pheromone compositions
- chemical catalysts
- water treatment systems
- solid phase micro-extraction
- glycopeptide compositions
- glass microparticle compositions
Examples include:
- European Patent No. 2 510 088 (“Oncolytic Rhabdovirus”)
- European Patent No. 2 718 427 (“Compositions for Glioblastoma treatment”)
- European Patent No. 3 061 345 (“Sex pheromone derivatives, and methods and uses thereof”)
- PCT Application No. CA2016/050622 (“Ligand for catalyst or pre-catalyst and method of forming C(sp2)-N bond”)
- PCT Application No. CA2018/051078 (“Chiral catalyst and method for asymmetric reduction of an imine”)
- U.S. Patent No. 9,783,443 (“Treatment of water to extend half-life of ozone”)
- PCT Application No.s CA2015/050551, CA2015/050550, CA2017/050279, and CA2017/050562 (all related to solid phase micro-extraction)
Managed global patent portfolios related to:
- vaccine formulation and development
- devices for micro-extraction of biological analytes
- water treatment systems
- anti-cancer viruses
- delivery and detection of embolic particles

Allison Kehler

Practice Assistant

Location: Vancouver
Email: [email protected]
Phone: 604.687.5744

Expertise

Presentations & Publications

Publication

Co-Author, “Get a Competitive Advantage through Patent Database Mining,” Renewable Energy and Cleantech Canada, 2011.
Publication

Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd Edition, Borden Ladner Gervais LLP, 2011
Publication

Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd edition, Borden Ladner Gervais LLP, 2011.
Publication

Nauman & Bertozzi, “Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting,” Biochim Biophys Acta, 2001, 1568(2):147-54.
Publication

Jacobs, Nauman, et al., “Metabolic labeling of glycoproteins with chemical tags through unnatural sialic acid biosynthesis,” Methods in Enzymology, 2000, 327:260-75.

Beyond Our Walls

Professional Involvement

Member, Intellectual Property Institute of Canada (IPIC)
Member, joint liaison committee between patent branch management and IPIC patent agents

Awards & Recognition

Recognized in the 2026 (and since 2016) in the IAM Patent 1000 — The World's Leading Patent Practitioners (Prosecution - Highly Recommended)
Recognized in the 2026 edition and previous editions of Intellectual Asset Magazine's IAM Global Leaders
Recognized in the 2026 edition of Lexology Index (Patent Agents) (formerly known as Who's Who Legal: Canada)

Education

Registered Canadian Patent Agent, 2009
Registered U.S. Patent Agent for Canadian applicants, 2009

PhD (organic chemistry), University of California, Berkeley, 2002
BSc (chemical engineering), Massachusetts Institute of Technology, 1997

Experience

Experience

Insights & Events

Presentations & Publications

Beyond Our Walls

Professional Involvement

Awards & Recognition

Education